Literature DB >> 29483212

Inhibition of the Histone H3K27 Demethylase UTX Enhances Tumor Cell Radiosensitivity.

Barbara H Rath1, Isabella Waung1, Kevin Camphausen1, Philip J Tofilon2.   

Abstract

The processes mediating the repair of DNA double-strand breaks (DSB) are critical determinants of radiosensitivity and provide a source of potential targets for tumor radiosensitization. Among the events required for efficient DSB repair are a variety of post-translational histone modifications, including methylation. Because trimethylation of histone H3 on lysine 27 (H3K27me3) has been associated with chromatin condensation, which can influence DSB repair, we determined the effects of radiation on H3K27me3 levels in tumor and normal cell lines. Irradiation of tumor cells resulted in a rapid loss of H3K27me3, which was prevented by the siRNA-mediated knockdown of the H3K27 demethylase UTX. Knockdown of UTX also enhanced the radiosensitivity of each tumor cell line. Treatment of tumor cells with the H3K27 demethylase inhibitor GSKJ4 immediately before irradiation prevented the radiation-induced decrease in H3K27me3 and enhanced radiosensitivity. As determined by neutral comet analysis and γH2AX expression, this GSKJ4 treatment protocol inhibited the repair of radiation-induced DSBs. Consistent with in vitro results, treatment of mice bearing leg tumor xenografts with GSKJ4 significantly enhance radiation-induce tumor growth delay. In contrast with results generated from tumor cell lines, radiation had no effect on H3K27me3 levels in normal fibroblast cell lines and GSKJ4 did not enhance their radiosensitivity. These data suggest that H3K27me3 demethylation contributes to DSB repair in tumor cells and that UTX, the demethylase responsible, provides a target for selective tumor cell radiosensitization. Mol Cancer Ther; 17(5); 1070-8. ©2018 AACR. ©2018 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29483212      PMCID: PMC5932086          DOI: 10.1158/1535-7163.MCT-17-1053

Source DB:  PubMed          Journal:  Mol Cancer Ther        ISSN: 1535-7163            Impact factor:   6.261


  42 in total

Review 1.  Patching Broken DNA: Nucleosome Dynamics and the Repair of DNA Breaks.

Authors:  Ozge Gursoy-Yuzugullu; Nealia House; Brendan D Price
Journal:  J Mol Biol       Date:  2015-11-26       Impact factor: 5.469

2.  Impact of H3K27 Demethylase Inhibitor GSKJ4 on NSCLC Cells Alone and in Combination with Metformin.

Authors:  Hikaru Watarai; Masashi Okada; Kenta Kuramoto; Hiroyuki Takeda; Hirotsugu Sakaki; Shuhei Suzuki; Shizuka Seino; Hiroyuki Oizumi; Mitsuaki Sadahiro; Chifumi Kitanaka
Journal:  Anticancer Res       Date:  2016-11       Impact factor: 2.480

Review 3.  Chromatin remodeling at DNA double-strand breaks.

Authors:  Brendan D Price; Alan D D'Andrea
Journal:  Cell       Date:  2013-03-14       Impact factor: 41.582

Review 4.  Histone modifications and DNA double-strand break repair after exposure to ionizing radiations.

Authors:  Clayton R Hunt; Deepti Ramnarain; Nobuo Horikoshi; Puneeth Iyengar; Raj K Pandita; Jerry W Shay; Tej K Pandita
Journal:  Radiat Res       Date:  2013-02-01       Impact factor: 2.841

5.  Identification of JmjC domain-containing UTX and JMJD3 as histone H3 lysine 27 demethylases.

Authors:  Sunhwa Hong; Young-Wook Cho; Li-Rong Yu; Hong Yu; Timothy D Veenstra; Kai Ge
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-14       Impact factor: 11.205

Review 6.  Targeting EZH2 in cancer.

Authors:  Kimberly H Kim; Charles W M Roberts
Journal:  Nat Med       Date:  2016-02       Impact factor: 53.440

7.  A selective jumonji H3K27 demethylase inhibitor modulates the proinflammatory macrophage response.

Authors:  Laurens Kruidenier; Chun-wa Chung; Zhongjun Cheng; John Liddle; KaHing Che; Gerard Joberty; Marcus Bantscheff; Chas Bountra; Angela Bridges; Hawa Diallo; Dirk Eberhard; Sue Hutchinson; Emma Jones; Roy Katso; Melanie Leveridge; Palwinder K Mander; Julie Mosley; Cesar Ramirez-Molina; Paul Rowland; Christopher J Schofield; Robert J Sheppard; Julia E Smith; Catherine Swales; Robert Tanner; Pamela Thomas; Anthony Tumber; Gerard Drewes; Udo Oppermann; Dinshaw J Patel; Kevin Lee; David M Wilson
Journal:  Nature       Date:  2012-08-16       Impact factor: 49.962

Review 8.  The comet assay for DNA damage and repair: principles, applications, and limitations.

Authors:  Andrew R Collins
Journal:  Mol Biotechnol       Date:  2004-03       Impact factor: 2.860

9.  Histone H3 methylation links DNA damage detection to activation of the tumour suppressor Tip60.

Authors:  Yingli Sun; Xiaofeng Jiang; Ye Xu; Marina K Ayrapetov; Lisa A Moreau; Johnathan R Whetstine; Brendan D Price
Journal:  Nat Cell Biol       Date:  2009-09-27       Impact factor: 28.824

10.  Drosophila UTX coordinates with p53 to regulate ku80 expression in response to DNA damage.

Authors:  Chengwan Zhang; Zehui Hong; Wencui Ma; Da Ma; Yuchen Qian; Wei Xie; Feng Tie; Ming Fang
Journal:  PLoS One       Date:  2013-11-12       Impact factor: 3.240

View more
  15 in total

Review 1.  Repurposing Drugs for Cancer Radiotherapy: Early Successes and Emerging Opportunities.

Authors:  Mohammad K Khan; Tahseen H Nasti; Zachary S Buchwald; Ralph R Weichselbaum; Stephen J Kron
Journal:  Cancer J       Date:  2019 Mar/Apr       Impact factor: 3.360

2.  Stress Responses as Master Keys to Epigenomic Changes in Transcriptome and Metabolome for Cancer Etiology and Therapeutics.

Authors:  Atanu Mondal; Apoorva Bhattacharya; Vipin Singh; Shruti Pandita; Albino Bacolla; Raj K Pandita; John A Tainer; Kenneth S Ramos; Tej K Pandita; Chandrima Das
Journal:  Mol Cell Biol       Date:  2021-11-08       Impact factor: 5.069

3.  Small Molecule Inhibitors of KDM5 Histone Demethylases Increase the Radiosensitivity of Breast Cancer Cells Overexpressing JARID1B.

Authors:  Simone Pippa; Cecilia Mannironi; Valerio Licursi; Luca Bombardi; Gianni Colotti; Enrico Cundari; Adriano Mollica; Antonio Coluccia; Valentina Naccarato; Giuseppe La Regina; Romano Silvestri; Rodolfo Negri
Journal:  Molecules       Date:  2019-05-04       Impact factor: 4.411

4.  JARID1B expression and its function in DNA damage repair are tightly regulated by miRNAs in breast cancer.

Authors:  Ivano Mocavini; Simone Pippa; Valerio Licursi; Paola Paci; Daniela Trisciuoglio; Cecilia Mannironi; Carlo Presutti; Rodolfo Negri
Journal:  Cancer Sci       Date:  2019-03-18       Impact factor: 6.716

Review 5.  The Critical Role of Hypoxic Microenvironment and Epigenetic Deregulation in Esophageal Cancer Radioresistance.

Authors:  Catarina Macedo-Silva; Vera Miranda-Gonçalves; Rui Henrique; Carmen Jerónimo; Isabel Bravo
Journal:  Genes (Basel)       Date:  2019-11-14       Impact factor: 4.096

Review 6.  Histone Modifications in Stem Cell Development and Their Clinical Implications.

Authors:  Moritz Völker-Albert; Abel Bronkhorst; Stefan Holdenrieder; Axel Imhof
Journal:  Stem Cell Reports       Date:  2020-12-08       Impact factor: 7.765

Review 7.  A Perspective of Epigenetic Regulation in Radiotherapy.

Authors:  Qin Peng; Kegui Weng; Shitian Li; Richard Xu; Yingxiao Wang; Yongzhong Wu
Journal:  Front Cell Dev Biol       Date:  2021-02-18

Review 8.  The Role of Histone Lysine Methylation in the Response of Mammalian Cells to Ionizing Radiation.

Authors:  Elena Di Nisio; Giuseppe Lupo; Valerio Licursi; Rodolfo Negri
Journal:  Front Genet       Date:  2021-03-30       Impact factor: 4.772

9.  EZH2 and KDM6B Expressions Are Associated with Specific Epigenetic Signatures during EMT in Non Small Cell Lung Carcinomas.

Authors:  Camille Lachat; Diane Bruyère; Amandine Etcheverry; Marc Aubry; Jean Mosser; Walid Warda; Michaël Herfs; Elodie Hendrick; Christophe Ferrand; Christophe Borg; Régis Delage-Mourroux; Jean-Paul Feugeas; Michaël Guittaut; Eric Hervouet; Paul Peixoto
Journal:  Cancers (Basel)       Date:  2020-12-05       Impact factor: 6.639

Review 10.  Lung Cancer Therapy Targeting Histone Methylation: Opportunities and Challenges.

Authors:  Yuchen Chen; Xinran Liu; Yangkai Li; Chuntao Quan; Ling Zheng; Kun Huang
Journal:  Comput Struct Biotechnol J       Date:  2018-06-20       Impact factor: 7.271

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.